Outlook Therapeutics Inc. (NASDAQ: OTLK)
$5.0900
-0.0400 ( -0.97% ) 132.7K
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Data
Open
$5.0900
Previous close
$5.1300
Volume
132.7K
Market cap
$120.41M
Day range
$4.9860 - $5.2550
52 week range
$4.6100 - $12.8499
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Apr 15, 2024 |
| 8-k | 8K-related | 16 | Apr 12, 2024 |
| 8-k | 8K-related | 13 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Mar 29, 2024 |
| 8-k | 8K-related | 13 | Mar 26, 2024 |
| 4 | Insider transactions | 1 | Mar 22, 2024 |
| 4 | Insider transactions | 1 | Mar 22, 2024 |
| 4 | Insider transactions | 1 | Mar 22, 2024 |
| 4 | Insider transactions | 1 | Mar 20, 2024 |
| 8-k | 8K-related | 14 | Mar 18, 2024 |